Biolife Solutions (BLFS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Sales | 96,214 | 74,647 | 68,016 | 76,239 | 119,156 |
| Cost of Goods | 34,096 | 24,551 | 26,698 | 29,328 | 82,108 |
| Gross Profit | 62,118 | 50,096 | 41,318 | 46,911 | 37,048 |
| Operating Expenses | 78,816 | 55,124 | 59,221 | 53,162 | 72,316 |
| Operating Income | -16,602 | -4,477 | -17,205 | -5,923 | -35,160 |
| Interest Expense | 0 | 0 | 0 | 284 | 0 |
| Other Income | 4,521 | -4,346 | 4,984 | 1,359 | 6,134 |
| Pre-tax Income | -12,081 | -8,823 | -12,221 | -4,848 | -29,026 |
| Income Tax | 49 | -38 | -64 | -5,236 | -20,118 |
| Net Income Continuous | -12,130 | -8,785 | -12,157 | 388 | -8,908 |
| Net Income Discontinuous | 7,535 | -11,399 | -55,845 | -140,193 | N/A |
| Net Income | $-4,595 | $-20,184 | $-68,002 | $-139,805 | $-8,908 |
| EPS Basic Total Ops | -0.09 | -0.44 | -1.55 | -3.29 | -0.23 |
| EPS Basic Continuous Ops | -0.25 | -0.19 | -0.28 | 0.01 | -0.23 |
| EPS Basic Discontinuous Ops | 0.16 | -0.25 | -1.27 | -3.30 | N/A |
| EPS Diluted Total Ops | -0.10 | -0.44 | -1.55 | -3.25 | -0.23 |
| EPS Diluted Continuous Ops | -0.25 | -0.19 | -0.28 | 0.01 | -0.23 |
| EPS Diluted Discontinuous Ops | 0.15 | -0.25 | -1.27 | -3.26 | N/A |
| EPS Diluted Before Non-Recurring Items | 0.13 | -0.07 | -1.04 | -0.69 | -0.55 |
| EBITDA(a) | $-11,915 | $4,184 | $-4,897 | $10,567 | $-22,174 |